NIH-funded research R21 grant

Understanding how PTEN signaling affects B cell development in the immune system

Official title: The role of PTEN signaling in regulating germinal center B cell fate decision

Funded at Indiana University Indianapolis · NIH-10875634 · Data updated 2026-11-12

This study is looking at how a specific signaling process in B cells, which are important for fighting infections and responding to vaccines, can be adjusted to make vaccines work better and help treat autoimmune diseases where the body makes harmful antibodies.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startJune 26, 2023
Project endMay 31, 2026
Funding year2024
Award (this year)$198,125
NIH project number5R21AI175824-02
Project IDNIH-10875634 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with autoimmune disorders or those interested in the immune response to vaccines.

Less likely to help

Patients with non-autoimmune conditions or those not affected by B cell-related issues may not benefit from this research.

What this research studies

This research investigates the role of PTEN signaling in the fate decisions of germinal center B cells, which are crucial for generating memory B cells and long-lived plasma cells that help fight infections and respond to vaccines. The study aims to uncover how manipulating PTEN signaling can improve vaccine efficacy and treat autoimmune diseases caused by harmful antibodies. By examining the molecular mechanisms that guide B cells in their development, the research seeks to provide insights into better therapeutic strategies for managing autoimmune conditions.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for autoimmune diseases and enhanced vaccine responses.

How similar studies have gone: Previous research has shown promising results in manipulating B cell signaling pathways, indicating potential for success in this area.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Luo, Wei — Indiana University Indianapolis
  • Study coordinator: Luo, Wei

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.